CHEMICAL COMPOUNDS
The present invention describes novel compounds, or their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their medical uses. The compounds of the invention have activity as Janus Kinase inhibitors and are useful in the treatment or control of pruritus, associated...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French |
Published |
14.05.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention describes novel compounds, or their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their medical uses. The compounds of the invention have activity as Janus Kinase inhibitors and are useful in the treatment or control of pruritus, associated with allergic dermatitis, atopic dermatitis in animals, and other disorders and indications where immunosuppression/immunomodulation would be desirable. Also described herein are methods of treating pruritus and atopic dermatitis by administering the compounds of the invention, which are JAK 1 inhibitors.
La présente invention concerne de nouveaux composés, ou leurs sels pharmaceutiquement acceptables, des compositions pharmaceutiques les contenant, et leurs utilisations médicales. Les composés de l'invention présentent une activité en tant qu'inhibiteurs des Janus kinases et sont utiles dans le traitement du prurit ou la lutte contre le prurit, associé à une dermatite allergique, une dermatite atopique chez les animaux, et d'autres troubles et indications où l'immunosuppression/l'immunomodulation serait souhaitable. L'invention concerne également des méthodes de traitement du prurit et de la dermatite atopique par administration des composés selon l'invention, qui sont des inhibiteurs de JAK1. |
---|---|
Bibliography: | Application Number: WO2019US59634 |